Germany Nephrology and Urology Devices Market Report- Size Global Production, Volume, Value, Revenue and Growth Numbers Released in 2019 Report

ReportsnReports added Germany Nephrology and Urology Devices Market Research Report created by Report Consultant, which offers detailed insights, revenue details, and other information regarding the global market, and the various trends, drivers, restraints, opportunities, and market till 2028. Germany Nephrology and Urology Devices Market Report offers detailed information regarding the leading key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions and mergers, and market footprint. Germany Nephrology and Urology Devices Market also provides a comparative analysis of the market dynamics pre and post Covid19 outbreak.

Request for FREE PDF Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=3264664

Germany Nephrology and Urology Devices Market is a comprehensive databook report, covering key market data on the Germany Nephrology and Urology Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Renal Dialysis Equipment.

The Germany Nephrology and Urology Devices Market report provides key information and data on –
– Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
– 2019 company share and distribution share data for Nephrology and Urology Devices Market.
– Global corporate-level profiles of key companies operating within the Germany Nephrology and Urology Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope of this Report-
Germany Nephrology and Urology Devices is segmented as follows –
– Renal Dialysis Equipment

Reasons to Buy this REport-
The Germany Nephrology and Urology Devices Market report helps you to develop –
– Business strategies by identifying the key market segments poised for strong growth in the future.
– Market-entry and market expansion strategies.
– Design competition strategies by identifying who-stands-where in the market.
– Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
– Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Single User License: US $ 5995

Get FLAT 20% Discount on this Report @ https://www.reportsnreports.com/purchase.aspx?name=3264664

Table of Contents
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Nephrology and Urology Devices Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8
3 Nephrology and Urology Devices Market, Germany 10
3.1 Nephrology and Urology Devices Market, Germany, Revenue ($m), 2015-2025 10
3.2 Nephrology and Urology Devices Market, Germany, Revenue ($m), 2015-2025 11
3.3 Nephrology and Urology Devices Market, Germany, Volume (Units), 2015-2025 13
3.4 Nephrology and Urology Devices Market, Germany, Volume (Units), 2015-2025 14
3.5 Nephrology and Urology Devices Market, Germany, Company Share by Revenue ($m), 2019 16
4 Renal Dialysis Equipment Market, Germany 18
4.1 Renal Dialysis Equipment Market, Germany, Revenue Mix ($m), 2019 18
4.2 Renal Dialysis Equipment Market, Germany, Segment Contribution (%), 2019 19
4.3 Renal Dialysis Equipment Market, Germany, Revenue ($m), 2015-2025 20
4.3.1 Dialysis Accessories Market, Germany, Revenue ($m), by Segment, 2015-2025 22
4.3.2 Dialysis Machines Market, Germany, Revenue ($m), by Segment, 2015-2025 25
4.3.3 Vascular Access Devices for Hemodialysis Market, Germany, Revenue ($m), by Segment, 2015-2025 27
4.4 Renal Dialysis Equipment Market, Germany, Volume (Units), 2015-2025 30
4.4.1 Dialysis Accessories Market, Germany, Volume (Units) by Segment, 2015-2025 32
4.4.2 Dialysis Machines Market, Germany, Volume (Units) by Segment, 2015-2025 35
4.4.3 Vascular Access Devices for Hemodialysis Market, Germany, Volume (Units) by Segment, 2015-2025 37
4.5 Renal Dialysis Equipment Market, Germany, Average Price ($), 2015-2025 40
4.6 Renal Dialysis Equipment Market, Germany, Distribution Share by Revenue ($m), 2019 42
4.7 Renal Dialysis Equipment Market, Germany, Company Share by Revenue ($m), 2019 43
5 Overview of Key Companies in Germany, Nephrology and Urology Devices Market 45
5.1 Fresenius Medical Care AG & Co KGaA 45
5.1.1 Company Overview 45
5.2 Nipro Corp 45
5.2.1 Company Overview 45
5.3 Baxter International Inc 45
5.3.1 Company Overview 45
5.4 B. Braun Melsungen AG 46
5.4.1 Company Overview 46
5.5 Asahi Kasei Corp 46
5.5.1 Company Overview 46
5.6 Toray Medical Co Ltd 46
5.6.1 Company Overview 46
5.7 CR Bard Inc 47
5.7.1 Company Overview 47
6 Nephrology and Urology Devices Market Pipeline Products 48
7 Financial Deals Landscape 50
7.1 Acquisition 50
7.1.1 Lubrizol Acquires Bavaria Medizin Technologie 50
7.2 Debt Offerings 51
7.2.1 Fresenius SE Raises USD838.6 Million in Offering 0.75% International Bonds Due 2028 51
7.2.2 Fresenius Medical Care Raises USD720 Million in Private Placement of 0.250% Bonds Due 2023 52
7.2.3 Fresenius Medical Care Raises USD553.7 Million in Private Placement of 1.250% Bonds Due 2029 53
7.2.4 Fresenius Medical Care Raises USD664.5 Million in Private Placement of 0.625% Bonds Due 2026 54
7.3 Partnerships 55
7.3.1 Osprey Medical to Enter into Distribution Agreement with GE Healthcare 55
8 Recent Developments 56
8.1 Corporate Communications 56
8.1.1 Dec 19, 2019: Dr. Karl Schneider retiring from Supervisory Board of Fresenius Management SE and named honorary member – Wolfgang Kirsch to join at new year 56
8.1.2 Dec 16, 2019: Jean-Claude Dubacher named Chairman and Chief Executive Officer of B. Braun Medical 56
8.1.3 Oct 29, 2019: Fresenius Medical Care appoints Dr. Frank Maddux to management board, makes global chief medical officer a board position 57
8.1.4 Sep 30, 2019: Sanofi : New England Journal of Medicine publishes data showing improved survival with Jevtana (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer 57
8.1.5 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership 59
8.1.6 Aug 27, 2019: Fresenius Medical Care appoints Helen Giza as Chief Financial Officer 59
8.1.7 Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers 60
8.1.8 Jul 19, 2019: Fresenius Medical Care celebrates 40th anniversary of Schweinfurt plant, company’s largest for dialysis machines 61
8.1.9 May 16, 2019: Fresenius Medical Care stays on course for growth – Annual General Meeting approves 22nd straight dividend increase 61
8.2 Financial Announcements 62
8.2.1 Feb 20, 2020: Fresenius reports 16th consecutive record year – After significant investments in 2019, company expects healthy growth in 2020 and confirms medium-term growth targets 62
8.2.2 Feb 19, 2020: Fresenius Medical Care achieves 2019 guidance and confirms 2020 outlook of sustainable, profitable growth 66
8.2.3 Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth – outlook confirmed 69
8.2.4 Nov 12, 2019: TMS program hosts open house to introduce Deep Transcranial Magnetic Stimulation (Deep TMS) Helmet to treat major depressive disorder (MDD) and Obsessive-Compulsive Disorder (OCD) 71
8.2.5 Oct 29, 2019: Fresenius Medical Care again delivers strong organic growth in the third quarter 74
8.2.6 Aug 13, 2019: Ritter Pharmaceuticals appoints esteemed gastroenterologist Anthony J. Lembo, M.D. to its medical advisory board 78
8.2.7 Aug 02, 2019: HARTMANN GROUP achieves sales growth of 3.7% in the first half of 2019 79
8.2.8 Jul 29, 2019: Siemens Healthineers continues to drive growth forward 80
8.2.9 Jun 25, 2019: Theralase brain cancer pre-clinical research accepted for publication 82
8.2.10 May 21, 2019: Bellerophon presents additional positive data from cohort 1 of ongoing Phase 2/3 study of INOpulse for treatment of Pulmonary Hypertension associated with Interstitial Lung Disease at American Thoracic Society 115th International Conference 84
8.2.11 May 10, 2019: HARTMANN starts the 2019 financial year with a 4% rise in sales 87
8.2.12 May 10, 2019: HARTMANN GROUP starts the 2019 financial year with a 4% rise in sales 88
8.2.13 May 08, 2019: WISE starts enrolment in cortical strip electrodes study 89
8.2.14 May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter 90
8.2.15 May 02, 2019: Fresenius makes solid start to 2019 and confirms Group guidance 91
8.3 Government and Public Interest 95
8.3.1 Feb 22, 2020: Novel data on sphingotec’s biomarkers for acute and critical care settings to be presented at AKI & CRRT 2020 95
8.4 Other Significant Developments 96
8.4.1 Mar 05, 2020: ADDvise signs a new agreement with Laborie with a total order value of at least MSEK 50 96
8.4.2 Jan 23, 2020: LB Pharmaceuticals starts dosing of schizophrenia drug 96
8.4.3 Jan 23, 2020: VisiQuate announces deployment of AI-based Analytics for Fresenius Medical Care 97
8.4.4 Oct 22, 2019: Donate Life America and the Fresenius Medical Care Foundation announce groundbreaking National, Universal Living Donor Kidney Registry 97
8.4.5 Sep 30, 2019: Interleukin 11 identified as new therapeutic target for Idiopathic Pulmonary Fibrosis 98
8.4.6 Jul 30, 2019: Fresenius raises Group sales growth guidance after good second quarter 100
8.4.7 Jul 10, 2019: Fresenius Medical invests in remote monitoring firm BioIntelliSense 105
8.4.8 Jul 10, 2019: Fresenius Medical Care sees U.S. plans for changes to kidney disease care as positive reinforcement of company’s strategy 106
8.5 Product News 106
8.5.1 Nov 06, 2019: Fresenius Medical Care North America presents new insights for kidney Care at the American Society of Nephrology (ASN) Annual Kidney Week 106
8.5.2 Nov 04, 2019: Fresenius Medical Care North America announces availability of advanced water purification systems for Hemodialysis 108
8.5.3 Aug 28, 2019: Fresenius Medical Care: Recall of 4008 bloodlines (AV-Set B-R F00001124 and AV-Set SRB-R F00000257) due to blood leakages 108
8.6 Strategy And Business Planning 109
8.6.1 Apr 01, 2020: Fresenius Medical Care partners with other dialysis providers to combat coronavirus pandemic in the U.S. 109
8.6.2 Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses 109
8.6.3 Aug 05, 2019: Fresenius Helios expands preventive medicine offering 110
8.6.4 Jul 03, 2019: Fresenius Medical Care expands clinical research activities 110
8.6.5 Apr 08, 2019: Fresenius Kabi celebrates $100 M Wilson Pharma expansion 111
9 Appendix 112
9.1 Research Methodology 113
9.1.1 Coverage 113
9.1.2 Secondary Research 113
9.1.3 Primary Research 114
9.1.4 Market Modeling and Forecasting 114
9.1.5 Company Share Analysis 116
9.1.6 Distribution Share Analysis 116
9.1.7 Benchmarking 117
9.2 GlobalData Consulting 117
9.3 Contact Us 118
9.4 Disclaimer 118

Share This Post